<abstract xmlns="http://www.w3.org/1999/xhtml"><p>Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) improves the prognosis in selected patients with peritoneal surface malignancies but it is an extensive procedure predisposing to major complications. Among them renal toxicity was reported. Severe renal insufficiency is considered a contraindication for this complex procedure. We present a patient with diabetic nephropathy with renal insufficiency KDOQI 3 and peritoneal metastasis from sigmoid adenocarcinoma with a good clinical outcome after CRS with HIPEC, highlighting the anesthetic precautions considered for this particular clinical case.</p></abstract>

Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) improves the prognosis in selected patients with peritoneal surface malignancies but it is an extensive procedure predisposing to major complications. Among them renal toxicity was reported. Severe renal insufficiency is considered a contraindication for this complex procedure. We present a patient with diabetic nephropathy with renal insufficiency KDOQI 3 and peritoneal metastasis from sigmoid adenocarcinoma with a good clinical outcome after CRS with HIPEC, highlighting the anesthetic precautions considered for this particular clinical case.

Cytoreduction with Hyperthermic Intraperitoneal Chemotherapy and Renal Insufficiency Related to Diabetes Mellitus: An Anesthetic Challenge

Department of Surgery, Regional Institute of Gastroenterology and Hepatology “Prof. Dr. Octavian Fodor”

Department of Anesthesiology and Intensive Care Medicine

University of Medicine and Pharmacy „Iuliu Hatieganu”

Department of Gastroenterology, Regional Institute of Gastroenterology and Hepatology, “Prof. Dr. Octavian Fodor”

The Journal of Critical Care Medicine

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) improves the prognosis in selected patients with peritoneal surface...

Cytoreduction with Hyperthermic Intraperitoneal Chemotherapy and Renal Insufficiency Related to Diabetes Mellitus: An Anesthetic Challenge

Publié en ligne: 08 nov. 2017

Pages: 158 - 161

Reçu: 17 juil. 2017

Accepté: 04 oct. 2017

DOI: https://doi.org/10.1515/jccm-2017-0027

Mots clés
acute renal failure, cytoreductive surgery, hyperthermic intraperitoneal chemotherapy, diabetes mellitus

© 2017 Adrian Bartos et al., published by De Gruyter Open

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Cytoreduction with Hyperthermic Intraperitoneal Chemotherapy and Renal Insufficiency Related to Diabetes Mellitus: An Anesthetic Challenge

Publié en ligne: 08 nov. 2017

Pages: 158 - 161

Reçu: 17 juil. 2017

Accepté: 04 oct. 2017

DOI: https://doi.org/10.1515/jccm-2017-0027

Mots clésacute renal failure, cytoreductive surgery, hyperthermic intraperitoneal chemotherapy, diabetes mellitus

© 2017 Adrian Bartos et al., published by De Gruyter Open

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Mots clés
acute renal failure, cytoreductive surgery, hyperthermic intraperitoneal chemotherapy, diabetes mellitus